NCT04177108 2024-03-27A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast CancerHoffmann-La RochePhase 3 Completed242 enrolled 12 charts
NCT00039780 2022-07-13Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly PaclitaxelBioNumerik Pharmaceuticals, Inc.Phase 3 Completed764 enrolled